Key result
Fasting serum visfatin levels in patients with anorexia nervosa (37.9 ng/ml) and bulimia nervosa (39.8 ng/ml) did not significantly differ from those of healthy control women (44.0 ng/ml).
Population
40 women, including 10 untreated patients with anorexia nervosa, 10 untreated patients with bulimia nervosa…
Design
Cross-sectional
Authors
Loading...
No difference in visfatin levels advises against its use as an eating-disorder biomarker; leaves open prospective validation.
Cross-Sectional (n=40)
No
Absolute Event Rate: 37.9% vs 44%
p-value: p=>0.05
Circulating visfatin levels are not affected by chronic malnutrition in anorexia nervosa or binge/purge eating behavior in bulimia nervosa.
Dostálová et al. (2009) conducted a cross-sectional in Anorexia nervosa and bulimia nervosa (n=40). Eating disorders (Anorexia nervosa and Bulimia nervosa) vs. Healthy age-matched women was evaluated on Fasting serum visfatin levels (ng/ml) (p=>0.05). Fasting serum visfatin levels in patients with anorexia nervosa (37.9 ng/ml) and bulimia nervosa (39.8 ng/ml) did not significantly differ from those of healthy control women (44.0 ng/ml).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: